Global COPD Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 17-Oct-2018
No. of pages: 134

COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors, steroids, combination therapies, etc.

Scope of the Report:

This report studies the COPD Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the COPD Drugs market by product type and applications/end industries.

One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.

The bronchodilators segment is one of the fastest growing segments of the COPD drugs market. Bronchodilators help relax bronchial muscles resulting in normal breathing. These drugs can be categorized into three types, namely beta-sympathomimetic, anticholinergics, and xanthine derivatives.

The global COPD Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of COPD Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- Pfizer

- Novartis

- GlaxoSmithKline

- Merck

- Abbott Laboratories

- Boehringer Ingelheim

- AstraZeneca

- Roche Holding AG

- Teva Pharmaceutical Industries

- Vectura Group

- Mylan NV

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Bronchodilators

- PDE-4 Inhibitors

- Steroids

- Combination Therapies

- Others

Market Segment by Applications, can be divided into

- Hospitals

- Clinics

- Others

Global COPD Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 COPD Drugs Market Overview
1.1 Product Overview and Scope of COPD Drugs
1.2 Classification of COPD Drugs by Types
1.2.1 Global COPD Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global COPD Drugs Revenue Market Share by Types in 2017
1.2.3 Bronchodilators
1.2.4 PDE-4 Inhibitors
1.2.5 Steroids
1.2.6 Combination Therapies
1.2.7 Others
1.3 Global COPD Drugs Market by Application
1.3.1 Global COPD Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global COPD Drugs Market by Regions
1.4.1 Global COPD Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) COPD Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) COPD Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COPD Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) COPD Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COPD Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of COPD Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 COPD Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 COPD Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 COPD Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 COPD Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 COPD Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 COPD Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 COPD Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Roche Holding AG
2.8.1 Business Overview
2.8.2 COPD Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Roche Holding AG COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical Industries
2.9.1 Business Overview
2.9.2 COPD Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Industries COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Vectura Group
2.10.1 Business Overview
2.10.2 COPD Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Vectura Group COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Mylan NV
2.11.1 Business Overview
2.11.2 COPD Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mylan NV COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global COPD Drugs Market Competition, by Players
3.1 Global COPD Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 COPD Drugs Players Market Share
3.2.2 Top 10 COPD Drugs Players Market Share
3.3 Market Competition Trend
4 Global COPD Drugs Market Size by Regions
4.1 Global COPD Drugs Revenue and Market Share by Regions
4.2 North America COPD Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe COPD Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific COPD Drugs Revenue and Growth Rate (2013-2018)
4.5 South America COPD Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa COPD Drugs Revenue and Growth Rate (2013-2018)
5 North America COPD Drugs Revenue by Countries
5.1 North America COPD Drugs Revenue by Countries (2013-2018)
5.2 USA COPD Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada COPD Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico COPD Drugs Revenue and Growth Rate (2013-2018)
6 Europe COPD Drugs Revenue by Countries
6.1 Europe COPD Drugs Revenue by Countries (2013-2018)
6.2 Germany COPD Drugs Revenue and Growth Rate (2013-2018)
6.3 UK COPD Drugs Revenue and Growth Rate (2013-2018)
6.4 France COPD Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia COPD Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy COPD Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific COPD Drugs Revenue by Countries
7.1 Asia-Pacific COPD Drugs Revenue by Countries (2013-2018)
7.2 China COPD Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan COPD Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea COPD Drugs Revenue and Growth Rate (2013-2018)
7.5 India COPD Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia COPD Drugs Revenue and Growth Rate (2013-2018)
8 South America COPD Drugs Revenue by Countries
8.1 South America COPD Drugs Revenue by Countries (2013-2018)
8.2 Brazil COPD Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina COPD Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia COPD Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue COPD Drugs by Countries
9.1 Middle East and Africa COPD Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia COPD Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE COPD Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt COPD Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria COPD Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa COPD Drugs Revenue and Growth Rate (2013-2018)
10 Global COPD Drugs Market Segment by Type
10.1 Global COPD Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global COPD Drugs Market Forecast by Type (2018-2023)
10.3 Bronchodilators Revenue Growth Rate (2013-2023)
10.4 PDE-4 Inhibitors Revenue Growth Rate (2013-2023)
10.5 Steroids Revenue Growth Rate (2013-2023)
10.6 Combination Therapies Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global COPD Drugs Market Segment by Application
11.1 Global COPD Drugs Revenue Market Share by Application (2013-2018)
11.2 COPD Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global COPD Drugs Market Size Forecast (2018-2023)
12.1 Global COPD Drugs Market Size Forecast (2018-2023)
12.2 Global COPD Drugs Market Forecast by Regions (2018-2023)
12.3 North America COPD Drugs Revenue Market Forecast (2018-2023)
12.4 Europe COPD Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific COPD Drugs Revenue Market Forecast (2018-2023)
12.6 South America COPD Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa COPD Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure COPD Drugs Picture
Table Product Specifications of COPD Drugs
Table Global COPD Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global COPD Drugs Revenue Market Share by Types in 2017
Figure Bronchodilators Picture
Figure PDE-4 Inhibitors Picture
Figure Steroids Picture
Figure Combination Therapies Picture
Figure Others Picture
Table Global COPD Drugs Revenue (Million USD) by Application (2013-2023)
Figure COPD Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market COPD Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer COPD Drugs Type and Applications
Table Pfizer COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis COPD Drugs Type and Applications
Table Novartis COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline COPD Drugs Type and Applications
Table GlaxoSmithKline COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck COPD Drugs Type and Applications
Table Merck COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories COPD Drugs Type and Applications
Table Abbott Laboratories COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim COPD Drugs Type and Applications
Table Boehringer Ingelheim COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca COPD Drugs Type and Applications
Table AstraZeneca COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table Roche Holding AG COPD Drugs Type and Applications
Table Roche Holding AG COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries COPD Drugs Type and Applications
Table Teva Pharmaceutical Industries COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Vectura Group Basic Information, Manufacturing Base and Competitors
Table Vectura Group COPD Drugs Type and Applications
Table Vectura Group COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan NV Basic Information, Manufacturing Base and Competitors
Table Mylan NV COPD Drugs Type and Applications
Table Mylan NV COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global COPD Drugs Revenue (Million USD) by Players (2013-2018)
Table Global COPD Drugs Revenue Share by Players (2013-2018)
Figure Global COPD Drugs Revenue Share by Players in 2016
Figure Global COPD Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players COPD Drugs Revenue Market Share in 2017
Figure Global Top 10 Players COPD Drugs Revenue Market Share in 2017
Figure Global COPD Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global COPD Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global COPD Drugs Revenue Market Share by Regions (2013-2018)
Figure Global COPD Drugs Revenue Market Share by Regions (2013-2018)
Figure Global COPD Drugs Revenue Market Share by Regions in 2017
Figure North America COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Europe COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific COPD Drugs Revenue and Growth Rate (2013-2018)
Figure South America COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa COPD Drugs Revenue and Growth Rate (2013-2018)
Table North America COPD Drugs Revenue by Countries (2013-2018)
Table North America COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure North America COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure North America COPD Drugs Revenue Market Share by Countries in 2017
Figure USA COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Canada COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico COPD Drugs Revenue and Growth Rate (2013-2018)
Table Europe COPD Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe COPD Drugs Revenue Market Share by Countries in 2017
Figure Germany COPD Drugs Revenue and Growth Rate (2013-2018)
Figure UK COPD Drugs Revenue and Growth Rate (2013-2018)
Figure France COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Russia COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Italy COPD Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific COPD Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific COPD Drugs Revenue Market Share by Countries in 2017
Figure China COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Japan COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Korea COPD Drugs Revenue and Growth Rate (2013-2018)
Figure India COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia COPD Drugs Revenue and Growth Rate (2013-2018)
Table South America COPD Drugs Revenue by Countries (2013-2018)
Table South America COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure South America COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure South America COPD Drugs Revenue Market Share by Countries in 2017
Figure Brazil COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia COPD Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa COPD Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa COPD Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa COPD Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia COPD Drugs Revenue and Growth Rate (2013-2018)
Figure UAE COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt COPD Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria COPD Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa COPD Drugs Revenue and Growth Rate (2013-2018)
Table Global COPD Drugs Revenue (Million USD) by Type (2013-2018)
Table Global COPD Drugs Revenue Share by Type (2013-2018)
Figure Global COPD Drugs Revenue Share by Type (2013-2018)
Figure Global COPD Drugs Revenue Share by Type in 2017
Table Global COPD Drugs Revenue Forecast by Type (2018-2023)
Figure Global COPD Drugs Market Share Forecast by Type (2018-2023)
Figure Global Bronchodilators Revenue Growth Rate (2013-2018)
Figure Global PDE-4 Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Steroids Revenue Growth Rate (2013-2018)
Figure Global Combination Therapies Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global COPD Drugs Revenue by Application (2013-2018)
Table Global COPD Drugs Revenue Share by Application (2013-2018)
Figure Global COPD Drugs Revenue Share by Application (2013-2018)
Figure Global COPD Drugs Revenue Share by Application in 2017
Table Global COPD Drugs Revenue Forecast by Application (2018-2023)
Figure Global COPD Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global COPD Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global COPD Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global COPD Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America COPD Drugs Revenue Market Forecast (2018-2023)
Figure Europe COPD Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific COPD Drugs Revenue Market Forecast (2018-2023)
Figure South America COPD Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa COPD Drugs Revenue Market Forecast (2018-2023)
  • Global Scalp Cooling Systems Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Scalp cooling is done by applying cold temperatures to your scalp during chemotherapy treatment for cancer. Scope of the Report: Scalp cooling system works by limiting blood flow to the scalp. This can reduce the amount of the chemo treatment that reaches your head, protecting your hair follicles from the chemo drugs. The global Scalp Cooling Systems market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CA......
  • Global Transfer Pipette Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 4900 Onwards        Pages: 95
    This report studies the global market size of Transfer Pipette in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transfer Pipette in these regions. This research report categorizes the global Transfer Pipette market by top players/brands, region, type and end user. This report also studies the global Transfer Pipette market status, competition landscape, market share, growth rate, future trends, market ......
  • Global Schizophrenia Treatments Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. Scope of the Report: The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. The global Schizophrenia Treatments market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. Th......
  • Global Forensic Products Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 4900 Onwards        Pages: 90
    This report studies the global market size of Forensic Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Forensic Products in these regions. This research report categorizes the global Forensic Products market by top players/brands, region, type and end user. This report also studies the global Forensic Products market status, competition landscape, market share, growth rate, future trends, mar......
  • Global SDS Poly Acrylamide Gel Electrophoresis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Polyacrylamide gel electrophoresis is a technique widely used in biochemistry, forensic chemistry, genetics, molecular biology and biotechnology to separate biological macromolecules, usually proteins or nucleic acids, according to their electrophoretic mobility. Scope of the Report: Polyacrylamide gel electrophoresis is a powerful tool used to analyze RNA samples. When polyacrylamide gel is denatured after electrophoresis, it provides information on the sample composition ......
  • Global Seborrheic Dermatitis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 117
    Seborrhoeic dermatitis is a long-term skin disorder. Scope of the Report: Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. The global Seborrheic Dermatitis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing I......
  • Global Secondary Hyperparathyroidism Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands. Scope of the Report: In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appear to affect the risk of early death. It does decrease the need for a parathyroidectomy but caused more issues with low blood calcium levels and vomiting.......
  • Global Secure Messaging in Healthcare Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Secure messaging is a server-based approach to protect sensitive data when sent beyond the corporate borders and provides compliance with industry regulations such as HIPAA, GLBA and SOX. Scope of the Report: Secure messages provide non-repudiation as the recipients are personally identified and transactions are logged by the secure email platform. The global Secure Messaging in Healthcare market is valued at xx million USD in 2017 and is expected to reach xx million......
  • Global Intravascular Warming Systems Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 4900 Onwards        Pages: 96
    This report studies the global market size of Intravascular Warming Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravascular Warming Systems in these regions. This research report categorizes the global Intravascular Warming Systems market by top players/brands, region, type and end user. This report also studies the global Intravascular Warming Systems market status, competition landscap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs